
DIM · Sartorius Stedim Biotech SA
191.20
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro18.83B
PE
76.90
EV/EBITDA
26.1
DIV Yield
0.3%
Payout Ratio
25%
MQV Rating
4Weak
As at 24/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- EMA 125 Breakup
- Fakey Shakey - Short
- Fakey Shakey - Short (Realtime)
- HALO 100
- HALO 200
- HALO All
- HALO Dividend Growth
- Hammer Bearish (Realtime)
- Near Resistance
Key Fundamentals
EPS 3 yr Growth
-71.30%
EBITDA Margin
29.20%
Operating Cashflow
€539m
Free Cash Flow Return
8.30%
ROIC
4.10%
Interest Coverage
5.70
Quick Ratio
0.50
Performance
52 weeks range
Low 150 - 224
Trade Value (12mth)
US$4,486,791.00
1 week
4.31%
1 month
15.66%
YTD
-7.06%
1 year
10.73%
All time high
551.00
Additional Data
Shares Outstanding (Fully Diluted)
97m
HALO Sector
Healthcare
Next Company Report Date
28-Jan-27
Next Ex Dividend Date
31-Mar-26
Next Dividend Pay Date
02-Apr-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Weak
Garp
Strong
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Very Weak
Growth
Earnings
Neutral
Dividends
Very Strong
Quality
Capital Efficiency
Neutral
Balance Sheet
Weak
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Sartorius AG | Public Company |
| Sartorius Stedim Biotech SA | Public Company |
| Inocap Gestion SAS | Subsidiary |